Publication | Closed Access

A cross-linking assay allows the detection of receptors for the somatostatin analogue, lanreotide in human breast tumours

Human Breast TumoursBreast OncologySomatic VariantEndocrine-related CancerCross-linking AssayMedicinePathologyBreast CancerMolecular DiagnosticsPharmacologyCancer ResearchTumor BiologySomatostatin Analogue